24-Jun-2021
Download PDF
Mesco Pharmaceuticals
MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 inter alia to consider and approve 1. To consider approve and take on record the Audited Financial Statements for the year ended 31" March 2021 & Audited Financial Results for the quarter and year ended 31st March 2021.
2. To receive and take on record the Auditors Report on Annual Accounts for the same period.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
